5-hydroxydecanoate has been researched along with B16 Melanoma in 1 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakaya, K | 1 |
| Mizuno, R | 1 |
| Ohhashi, T | 1 |
1 other study available for 5-hydroxydecanoate and B16 Melanoma
| Article | Year |
|---|---|
B16-BL6 melanoma cells release inhibitory factor(s) of active pump activity in isolated lymph vessels.
Topics: Animals; Anti-Arrhythmia Agents; Arginine; Biological Assay; Culture Media, Conditioned; Cyclooxygen | 2001 |